| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 833.9 Million | USD 1986.87 Million | 9.07% | 2024 |
FrequentlyAsked Questions
Particle therapy is an emerging segment of the larger radiotherapy domain in the healthcare industry.
The global particle therapy market is projected to grow owing to the increasing number of cancer patients across the globe.
According to a study, the global particle therapy market size was worth around USD 833.9 million in 2024 and is predicted to grow to around USD 1986.87 million by 2034.
The CAGR value of the particle therapy market is expected to be around 9.07% during 2025-2034.
The global particle therapy market is projected to witness the highest growth in North America.
The global particle therapy market is led by players like Varian Medical Systems, Inc., Ion Beam Applications S.A. (IBA), Optivus Proton Therapy, Inc., Hitachi, Ltd., ProNova Solutions, LLC, Mitsubishi Electric Corporation, RaySearch Laboratories AB, Accuray Incorporated, ProTom International, Danfysik A/S, Mevion Medical Systems, Provision Healthcare, Sumitomo Heavy Industries, Ltd., Elekta AB, and Advanced Oncotherapy plc.
The report explores crucial aspects of the particle therapy market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients